Literature DB >> 830771

Ultrastructure of the capillary loops in the dermal papillae of psoriasis.

I M Braverman, A Yen.   

Abstract

Electron microscopy was used to define the ultrastructure of the capillary loops in the dermal papillae of psoriatic lesions. Pustular psoriasis of von Zumbusch and psoriasis vulgaris were studied before and after treatment with the Goeckerman regimen. Capillary loops were reconstructed from 1-mum plastic-embedded sections. Ultrathin sections were taken at intervals for correlation with the 1-mum sections. There were no ultrastructural differences between the capillary loops in psoriasis vulgaris and pustular psoriasis. The intrapapillary portion of the loop was predominantly a venous capillary. Four basic ultrastructural loop patterns were recognized which can serve as markers in studying the responses of psoriatic loops in various experimental situations. Following 3 weeks of Goeckerman therapy, the morphology of psoriatic capillary loops changed from venous capillaries to arterial capillaries which are found in the papillae of normal skin. This transformation was observed to begin 48 to 72 hr after the initiation of therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830771     DOI: 10.1111/1523-1747.ep12485169

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

1.  Microangiectasias: structural regulators of lymphocyte transmigration.

Authors:  Timothy W Secomb; Moritz A Konerding; Charles A West; Mei Su; Alan J Young; Steven J Mentzer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

2.  Carbonic anhydrase--a marker for fenestrated capillaries in psoriasis.

Authors:  W Jungkunz; M Eichhorn; J Wörl; W C Marsch; H Holzmann
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

Review 3.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

4.  Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.

Authors:  A W R van Kuijk; P Reinders-Blankert; T J M Smeets; B A C Dijkmans; P P Tak
Journal:  Ann Rheum Dis       Date:  2006-05-25       Impact factor: 19.103

Review 5.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

Review 6.  Angiogenesis in psoriasis and psoriatic arthritis: clues to disease pathogenesis.

Authors:  Tai Teck Leong; Ursula Fearon; Douglas J Veale
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

7.  The formation of fenestrations and channels by capillary endothelium in vitro.

Authors:  A J Milici; M B Furie; W W Carley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Expression of Angiogenic Factors in Psoriasis Vulgaris.

Authors:  Lakshna Sankar; Dhanalakshmi Arumugam; Sudha Boj; Priyanka Pradeep
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Pityriasis rubra pilaris: a clinico-pathological and therapeutic study with special reference to histochemistry, autoradiography, and electron microscopy.

Authors:  O Braun-Falco; F Ryckmanns; C Schmoeckel; M Landthaler
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

10.  Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

Authors:  Peter M Elias; Jack Arbiser; Barbara E Brown; Heidemarie Rossiter; Mao-Qiang Man; Francesca Cerimele; Debra Crumrine; Roshan Gunathilake; Eung Ho Choi; Yoshikazu Uchida; Erwin Tschachler; Kenneth R Feingold
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.